<?xml version="1.0" encoding="UTF-8"?>
<p id="par0035">From the recent COVID-19 literature, no information can be extrapolated about asthma phenotypes, specifically about whether asthma was allergic or not. In a recent study that included paediatric and adult patients with asthma from three different cohorts, it was found that ACE2 expression was lowest in those with high levels of allergic sensitization, but non-atopic asthma was not associated with this reduced expression.
 <xref rid="bib0155" ref-type="bibr">
  <sup>11</sup>
 </xref> Given that ACE2 serves as the receptor for SARS-CoV-2, these data suggest that this expression may be a potential contributor, among several other factors, to reduced COVID-19 severity in patients with T2 inflammation,
 <xref rid="bib0155" ref-type="bibr">
  <sup>11</sup>
 </xref> namely in patients with allergic asthma but also with other allergic diseases, such allergic rhinitis, which are more prevalent in all age groups.
</p>
